166 related articles for article (PubMed ID: 17148591)
1. Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells.
Dutton A; Woodman CB; Chukwuma MB; Last JI; Wei W; Vockerodt M; Baumforth KR; Flavell JR; Rowe M; Taylor AM; Young LS; Murray PG
Blood; 2007 Mar; 109(6):2597-603. PubMed ID: 17148591
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression.
Ma X; Yang L; Xiao L; Tang M; Liu L; Li Z; Deng M; Sun L; Cao Y
PLoS One; 2011; 6(11):e24647. PubMed ID: 22096476
[TBL] [Abstract][Full Text] [Related]
3. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
[TBL] [Abstract][Full Text] [Related]
6. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.
Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG
Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2.
Eliopoulos AG; Davies C; Blake SS; Murray P; Najafipour S; Tsichlis PN; Young LS
J Virol; 2002 May; 76(9):4567-79. PubMed ID: 11932422
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
Siegler G; Kremmer E; Gonnella R; Niedobitek G
Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
Vockerodt M; Tesch H; Kube D
Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.
Fries KL; Miller WE; Raab-Traub N
J Virol; 1996 Dec; 70(12):8653-9. PubMed ID: 8970991
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-encoded LMP1 induces ectopic CD137 expression on Hodgkin and Reed-Sternberg cells via the PI3K-AKT-mTOR pathway.
Aravinth SP; Rajendran S; Li Y; Wu M; Yi Wong AH; Schwarz H
Leuk Lymphoma; 2019 Nov; 60(11):2697-2704. PubMed ID: 31058559
[TBL] [Abstract][Full Text] [Related]
14. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation.
Everly DN; Mainou BA; Raab-Traub N
J Virol; 2004 Dec; 78(24):13470-8. PubMed ID: 15564458
[TBL] [Abstract][Full Text] [Related]
15. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
16. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
17. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.
Pai S; O'Sullivan BJ; Cooper L; Thomas R; Khanna R
J Virol; 2002 Feb; 76(4):1914-21. PubMed ID: 11799186
[TBL] [Abstract][Full Text] [Related]
18. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
[TBL] [Abstract][Full Text] [Related]
19. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
Edwards RH; Marquitz AR; Raab-Traub N
mBio; 2015 Apr; 6(2):. PubMed ID: 25873381
[TBL] [Abstract][Full Text] [Related]
20. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
